Dr. Basem Goueli

Hematology
400 Medical Plz, Suite 10, 
Lake St Louis, MO 
Clinical Trials:Currently Recruiting for 1 Trial
400 Medical Plz, Suite 10, 
Lake St Louis, MO 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Basem Goueli is a Hematologist in Lake St Louis, Missouri. Dr. Goueli is rated as an Experienced provider by MediFind in the treatment of Hemochromatosis. His top areas of expertise are Chronic B-Cell Leukemia (CBCL), Richter Syndrome, Chronic Lymphocytic Leukemia (CLL), Follicular Lymphoma, and Bone Marrow Aspiration.

His clinical research consists of co-authoring 2 peer reviewed articles and participating in 12 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology
Licenses
Internal Medicine in NY
Hospital Affiliations
Ssm St Joseph Health Center
Cuyuna Regional Medical Center
Ssm Health Depaul Hospital St Louis
Ssm St Joseph Hospital West
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

SSM MEDICAL GROUP INC
400 Medical Plz, Suite 10, Lake St Louis, MO 63367
Other Locations
CUYUNA REGIONAL MEDICAL CENTER
320 E Main St, Crosby, MN 56441

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

12 Clinical Trials

A Randomized Phase III Trial for Surgically Resected Early Stage Non-small Cell Lung Cancer: Crizotinib Versus Observation for Patients With Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
A Randomized Phase III Trial for Surgically Resected Early Stage Non-small Cell Lung Cancer: Crizotinib Versus Observation for Patients With Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
Enrollment Status: Recruiting
Publish Date: July 03, 2024
Intervention Type: Other, Drug
Study Drug: Crizotinib
Study Phase: Phase 3
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Enrollment Status: Active_not_recruiting
Publish Date: December 17, 2025
Intervention Type: Other, Procedure, Biological, Drug
Study Phase: Not Applicable
A Phase II Clinical Trial Platform of Sensitization Utilizing Total Neoadjuvant Therapy (TNT) in Rectal Cancer
A Phase II Clinical Trial Platform of Sensitization Utilizing Total Neoadjuvant Therapy (TNT) in Rectal Cancer
Enrollment Status: Completed
Publish Date: December 04, 2025
Intervention Type: Drug, Radiation, Biological
Study Phase: Phase 2
Randomized Study of Erlotinib Vs Observation in Patients With Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)
Randomized Study of Erlotinib Vs Observation in Patients With Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)
Enrollment Status: Active_not_recruiting
Publish Date: December 04, 2025
Intervention Type: Other, Drug
Study Drug: Erlotinib Hydrochloride
Study Phase: Phase 3
Randomized Phase II Open Label Study of Lenalidomide R-CHOP (R2CHOP) vs. RCHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone) in Patients With Newly Diagnosed Diffuse Large B Cell Lymphoma
Randomized Phase II Open Label Study of Lenalidomide R-CHOP (R2CHOP) vs. RCHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone) in Patients With Newly Diagnosed Diffuse Large B Cell Lymphoma
Enrollment Status: Active_not_recruiting
Publish Date: November 28, 2025
Intervention Type: Drug, Biological, Other
Study Drugs: Cyclophosphamide, Doxorubicin Hydrochloride, Lenalidomide, Prednisone, Rituximab, Vincristine Sulfate
Study Phase: Phase 2
A Phase II/III Randomized Trial of Veliparib or Placebo in Combination With Adjuvant Temozolomide in Newly Diagnosed Glioblastoma With MGMT Promoter Hypermethylation
A Phase II/III Randomized Trial of Veliparib or Placebo in Combination With Adjuvant Temozolomide in Newly Diagnosed Glioblastoma With MGMT Promoter Hypermethylation
Enrollment Status: Active_not_recruiting
Publish Date: November 28, 2025
Intervention Type: Other, Drug
Study Drugs: Temozolomide, Veliparib
Study Phase: Phase 2/Phase 3
Adjuvant Nivolumab in Resected Lung Cancers (ANVIL)-A Randomized Phase III Study of Nivolumab After Surgical Resection and Adjuvant Chemotherapy in Non-Small Cell Lung Cancers
Adjuvant Nivolumab in Resected Lung Cancers (ANVIL)-A Randomized Phase III Study of Nivolumab After Surgical Resection and Adjuvant Chemotherapy in Non-Small Cell Lung Cancers
Enrollment Status: Active_not_recruiting
Publish Date: November 17, 2025
Intervention Type: Procedure, Biological, Other
Study Drug: Nivolumab
Study Phase: Phase 3
The National Myelodysplastic Syndromes Natural History Study
The National Myelodysplastic Syndromes Natural History Study
Enrollment Status: Active_not_recruiting
Publish Date: July 02, 2025
Intervention Type: Other
Phase II Trial of Atezolizumab in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Phase II Trial of Atezolizumab in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Enrollment Status: Completed
Publish Date: May 22, 2025
Intervention Type: Drug
Study Drug: Atezolizumab
Study Phase: Phase 2
Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer
Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: December 27, 2024
Intervention Type: Drug, Other
Study Drugs: Anastrozole, Everolimus, Exemestane, Goserelin Acetate, Letrozole, Leuprolide Acetate, Tamoxifen Citrate
Study Phase: Phase 3
Pivotal, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 150kHz) Concomitant With Gemcitabine and Nab-paclitaxel for Front-line Treatment of Locally-advanced Pancreatic Adenocarcinoma
Pivotal, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 150kHz) Concomitant With Gemcitabine and Nab-paclitaxel for Front-line Treatment of Locally-advanced Pancreatic Adenocarcinoma
Enrollment Status: Completed
Publish Date: October 31, 2024
Intervention Type: Drug, Device
Study Drugs: Gemcitabine, Nab-paclitaxel
Study Phase: Phase 3
A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial
A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial
Enrollment Status: Terminated
Publish Date: April 05, 2023
Intervention Type: Other, Drug
Study Drug: Aspirin
Study Phase: Phase 3
View 11 Less Clinical Trials

2 Total Publications

Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML.
Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML.
Journal: The New England journal of medicine
Published: May 10, 2013
Similar Doctors
Advanced in Hemochromatosis
Dr. Bhaskara V. Gadi
Hematology Oncology | Hematology | Oncology
Advanced in Hemochromatosis
Dr. Bhaskara V. Gadi
Hematology Oncology | Hematology | Oncology

Mercy Clinic Oncology LLC

1350 Us Hwy 61, 
Festus, MO 
 (46.5 miles away)
636-931-3655
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Bhaskara Gadi is a Hematologist Oncology specialist and a Hematologist in Festus, Missouri. Dr. Gadi is rated as a Distinguished provider by MediFind in the treatment of Hemochromatosis. His top areas of expertise are Lymphofollicular Hyperplasia, Lymphoid Hyperplasia, Iron Deficiency Anemia, and Lynch Syndrome. Dr. Gadi is currently accepting new patients.

Advanced in Hemochromatosis
Dr. Syed M. Arshad
Hematology Oncology | Oncology | Hematology
Advanced in Hemochromatosis
Dr. Syed M. Arshad
Hematology Oncology | Oncology | Hematology

Mercy Clinic Specialists Services-Illinois LLC

2227 Vadalabene Dr, Suite 200, 
Maryville, IL 
 (45.0 miles away)
618-288-1140
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Syed Arshad is a Hematologist Oncology specialist and an Oncologist in Maryville, Illinois. Dr. Arshad is rated as a Distinguished provider by MediFind in the treatment of Hemochromatosis. His top areas of expertise are Upper Tract Urothelial Carcinoma (UTUC), Colorectal Cancer, Anemia, and Familial Colorectal Cancer. Dr. Arshad is currently accepting new patients.

Advanced in Hemochromatosis
Dr. Pascale A. Salem
Hematology Oncology | Hematology | Oncology
Advanced in Hemochromatosis
Dr. Pascale A. Salem
Hematology Oncology | Hematology | Oncology

Mercy Clinic Oncology LLC

15945 Clayton Rd, Suite 120, 
Ballwin, MO 
 (16.9 miles away)
636-256-5000
Languages Spoken:
English, Arabic, French
See accepted insurances
Accepting New Patients

Pascale Salem is a Hematologist Oncology specialist and a Hematologist in Ballwin, Missouri. Dr. Salem is rated as a Distinguished provider by MediFind in the treatment of Hemochromatosis. Her top areas of expertise are Paget Disease of the Breast, Familial Colorectal Cancer, Colorectal Cancer, and Neuroendocrine Tumor. Dr. Salem is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Goueli's expertise for a condition
ConditionClose
      View All 57 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile